The popularity of Sildenafil initially fueled a surge for the drug industry, but recent shifts present a murky picture for shareholders. Off-patent versions are eroding earnings, and persistent litigation add more https://deweydnnj877411.thekatyblog.com/39369403/sildenafil-and-big-pharma-a-precarious-bet